POETA, ELEONORA
POETA, ELEONORA
DIPARTIMENTO DI FARMACIA E BIOTECNOLOGIE
Assegnisti
Coumarin-azasugar-benzyl conjugates as non-neurotoxic dual inhibitors of butyrylcholinesterase and cancer cell growth
2024 Vaaland Holmgard I.C.; Gonzalez-Bakker A.; Poeta E.; Puerta A.; Fernandes M.X.; Monti B.; Fernandez-Bolanos J.G.; Padron J.M.; Lopez I.; Lindback E.
First in Class Dual Non-ATP-Competitive Glycogen Synthase Kinase 3β/Histone Deacetylase Inhibitors as a Potential Therapeutic to Treat Alzheimer’s Disease
2024 Santini A.; Tassinari E.; Poeta E.; Loi M.; Ciani E.; Trazzi S.; Piccarducci R.; Daniele S.; Martini C.; Pagliarani B.; Tarozzi A.; Bersani M.; Spyrakis F.; Danková D.; Olsen C.A.; Soldati R.; Tumiatti V.; Montanari S.; De Simone A.; Milelli A.
Integrating a quinone substructure into histone deacetylase inhibitors to cope with Alzheimer's disease and cancer
2024 Guardigni M.; Greco G.; Poeta E.; Santini A.; Tassinari E.; Bergamini C.; Zalambani C.; De Simone A.; Andrisano V.; Uliassi E.; Monti B.; Bolognesi M.L.; Fimognari C.; Milelli A.
Metabolic supplementations and epigenetic alterations in in vitro AGC1 deficiency models
2024 Giorgia Babini, Eleonora Poeta, Francesca Massenzio, Federico Manuel Giorgi, Laura Mercolini, Massimo Lasorsa, Barbara Monti
Transcriptional and metabolic effects of aspartate-glutamate carrier isoform 1 (AGC1) downregulation in mouse oligodendrocyte precursor cells (OPCs)
2024 Nicola Balboni, Giorgia Babini, Eleonora Poeta, Michele Protti, Laura Mercolini, Maria Chiara Magnifico, Simona Nicole Barile, Francesca Massenzio, Antonella Pignataro, Federico M Giorgi, Francesco Massimo Lasorsa, Barbara Monti
Unveiling the role of exosomal miRNAs in the spreading of neuroinflammation
2024 Francesca De Chirico, Francesca Massenzio, Eleonora Poeta, Giorgia Babini, Sabrina Petralla, Manon Elise Libotte, Giampaolo Zuccheri, Barbara Monti
Dual-Acting Small Molecules: Subtype-Selective Cannabinoid Receptor 2 Agonist/Butyrylcholinesterase Inhibitor Hybrids Show Neuroprotection in an Alzheimer's Disease Mouse Model.
2023 Philipp Spatz, Sophie A M Steinmüller , Anna Tutov , Eleonora Poeta , Axelle Morilleau , Allison Carles , Marie H Deventer , Julian Hofmann , Christophe P Stove , Barbara Monti , Tangui Maurice , Michael Decker
Targeted quantitative metabolic profiling of brain-derived cell cultures by semi-automated MEPS and LC-MS/MS
2023 Michele Protti, Marco Cirrincione, Sarah Palano, Eleonora Poeta, Giorgia Babini, Maria Chiara Magnifico, Simona Nicole Barile, Nicola Balboni, Francesca Massenzio, Mohammadreza Mahdavijalal, Federico M. Giorgi, Roberto Mandrioli, Francesco M. Lasorsa, Barbara Monti, Laura Mercolini
Discovery of Dual Aβ/Tau Inhibitors and Evaluation of Their Therapeutic Effect on a Drosophila Model of Alzheimer's Disease
2022 Gandini, Annachiara; Gonçalves, Ana Elisa; Strocchi, Silvia; Albertini, Claudia; Janočková, Jana; Tramarin, Anna; Grifoni, Daniela; Poeta, Eleonora; Soukup, Ondrej; Muñoz-Torrero, Diego; Monti, Barbara; Sabaté, Raimon; Bartolini, Manuela; Legname, Giuseppe; Bolognesi, Maria Laura
Histone Acetylation Defects in Brain Precursor Cells: A Potential Pathogenic Mechanism Causing Proliferation and Differentiation Dysfunctions in Mitochondrial Aspartate-Glutamate Carrier Isoform 1 Deficiency
2022 Poeta E.; Petralla S.; Babini G.; Renzi B.; Celauro L.; Magnifico M.C.; Barile S.N.; Masotti M.; De Chirico F.; Massenzio F.; Viggiano L.; Palmieri L.; Virgili M.; Lasorsa F.M.; Monti B.
New models of Parkinson’s like neuroinflammation in human microglia clone 3: Activation profiles induced by INF-γ plus high glucose and mitochondrial inhibitors
2022 Francesca De Chirico, Eleonora Poeta, Giorgia Babini, Iliana Piccolino, Barbara Monti, Francesca Massenzio*
Epigenetics and Communication Mechanisms in Microglia Activation with a View on Technological Approaches
2021 Sabrina Petralla, Francesca De Chirico, Andrea Miti, Ottavia Tartagni, Francesca Massenzio, Eleonora Poeta, Marco Virgili, Giampaolo Zuccheri, Barbara Monti
Melatonin- And Ferulic Acid-Based HDAC6 Selective Inhibitors Exhibit Pronounced Immunomodulatory Effects in Vitro and Neuroprotective Effects in a Pharmacological Alzheimer's Disease Mouse Model
2021 He F.; Chou C.J.; Scheiner M.; Poeta E.; Yuan Chen N.; Gunesch S.; Hoffmann M.; Sotriffer C.; Monti B.; Maurice T.; Decker M.
Selective Pseudo-irreversible Butyrylcholinesterase Inhibitors Transferring Antioxidant Moieties to the Enzyme Show Pronounced Neuroprotective Efficacy in Vitro and in Vivo in an Alzheimer's Disease Mouse Model
2021 Scheiner M.; Hoffmann M.; He F.; Poeta E.; Chatonnet A.; Monti B.; Maurice T.; Decker M.
Deficiency of Mitochondrial Aspartate-Glutamate Carrier 1 Leads to Oligodendrocyte Precursor Cell Proliferation Defects Both In Vitro and In Vivo
2019 Petralla S.; Pena-Altamira L.E.; Poeta E.; Massenzio F.; Virgili M.; Barile S.N.; Sbano L.; Profilo E.; Corricelli M.; Danese A.; Giorgi C.; Ostan R.; Capri M.; Pinton P.; Palmieri F.; Lasorsa F.M.; Monti B.
Dual-Acting Cholinesterase-Human Cannabinoid Receptor 2 Ligands Show Pronounced Neuroprotection in Vitro and Overadditive and Disease-Modifying Neuroprotective Effects in Vivo
2019 Scheiner M.; Dolles D.; Gunesch S.; Hoffmann M.; Nabissi M.; Marinelli O.; Naldi M.; Bartolini M.; Petralla S.; Poeta E.; Monti B.; Falkeis C.; Vieth M.; Hubner H.; Gmeiner P.; Maitra R.; Maurice T.; Decker M.
Tacrine-O-protected phenolics heterodimers as multitarget-directed ligands against Alzheimer's disease: Selective subnanomolar BuChE inhibitors
2019 Roldan-Pena J.M.; Romero-Real V.; Hicke J.; Maya I.; Franconetti A.; Lagunes I.; Padron J.M.; Petralla S.; Poeta E.; Naldi M.; Bartolini M.; Monti B.; Bolognesi M.; Lopez O.; Fernandez-Bolanos J.G.
Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
---|---|---|---|---|---|---|
Coumarin-azasugar-benzyl conjugates as non-neurotoxic dual inhibitors of butyrylcholinesterase and cancer cell growth | Vaaland Holmgard I.C.; Gonzalez-Bakker A.; Poeta E.; Puerta A.; Fernandes M.X.; Monti B.; Fernand...ez-Bolanos J.G.; Padron J.M.; Lopez I.; Lindback E. | 2024-01-01 | ORGANIC & BIOMOLECULAR CHEMISTRY | - | 1.01 Articolo in rivista | - |
First in Class Dual Non-ATP-Competitive Glycogen Synthase Kinase 3β/Histone Deacetylase Inhibitors as a Potential Therapeutic to Treat Alzheimer’s Disease | Santini A.; Tassinari E.; Poeta E.; Loi M.; Ciani E.; Trazzi S.; Piccarducci R.; Daniele S.; Mart...ini C.; Pagliarani B.; Tarozzi A.; Bersani M.; Spyrakis F.; Danková D.; Olsen C.A.; Soldati R.; Tumiatti V.; Montanari S.; De Simone A.; Milelli A. | 2024-01-01 | ACS CHEMICAL NEUROSCIENCE | - | 1.01 Articolo in rivista | acs-cn.pdf |
Integrating a quinone substructure into histone deacetylase inhibitors to cope with Alzheimer's disease and cancer | Guardigni M.; Greco G.; Poeta E.; Santini A.; Tassinari E.; Bergamini C.; Zalambani C.; De Simone... A.; Andrisano V.; Uliassi E.; Monti B.; Bolognesi M.L.; Fimognari C.; Milelli A. | 2024-01-01 | RSC MEDICINAL CHEMISTRY | - | 1.01 Articolo in rivista | d4md00175c.pdf; d4md00175c1.pdf |
Metabolic supplementations and epigenetic alterations in in vitro AGC1 deficiency models | Giorgia Babini, Eleonora Poeta, Francesca Massenzio, Federico Manuel Giorgi, Laura Mercolini, Ma...ssimo Lasorsa, Barbara Monti | 2024-01-01 | - | - | 4.02 Riassunto (Abstract) | - |
Transcriptional and metabolic effects of aspartate-glutamate carrier isoform 1 (AGC1) downregulation in mouse oligodendrocyte precursor cells (OPCs) | Nicola Balboni, Giorgia Babini, Eleonora Poeta, Michele Protti, Laura Mercolini, Maria Chiara Mag...nifico, Simona Nicole Barile, Francesca Massenzio, Antonella Pignataro, Federico M Giorgi, Francesco Massimo Lasorsa, Barbara Monti | 2024-01-01 | CELLULAR AND MOLECULAR BIOLOGY LETTERS | - | 1.01 Articolo in rivista | s11658-024-00563-z.pdf |
Unveiling the role of exosomal miRNAs in the spreading of neuroinflammation | Francesca De Chirico, Francesca Massenzio, Eleonora Poeta, Giorgia Babini, Sabrina Petralla, Ma...non Elise Libotte, Giampaolo Zuccheri, Barbara Monti | 2024-01-01 | NEUROLOGY INTERNATIONAL | - | 4.02 Riassunto (Abstract) | - |
Dual-Acting Small Molecules: Subtype-Selective Cannabinoid Receptor 2 Agonist/Butyrylcholinesterase Inhibitor Hybrids Show Neuroprotection in an Alzheimer's Disease Mouse Model. | Philipp Spatz, Sophie A M Steinmüller , Anna Tutov , Eleonora Poeta , Axelle Morilleau , Allison ...Carles , Marie H Deventer , Julian Hofmann , Christophe P Stove , Barbara Monti , Tangui Maurice , Michael Decker | 2023-01-01 | JOURNAL OF MEDICINAL CHEMISTRY | - | 1.01 Articolo in rivista | 2023 - Spatz et al JMC.pdf |
Targeted quantitative metabolic profiling of brain-derived cell cultures by semi-automated MEPS and LC-MS/MS | Michele Protti, Marco Cirrincione, Sarah Palano, Eleonora Poeta, Giorgia Babini, Maria Chiara Mag...nifico, Simona Nicole Barile, Nicola Balboni, Francesca Massenzio, Mohammadreza Mahdavijalal, Federico M. Giorgi, Roberto Mandrioli, Francesco M. Lasorsa, Barbara Monti, Laura Mercolini | 2023-01-01 | JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS | - | 1.01 Articolo in rivista | _metabolic profile brain cells JPBA 2023.pdf |
Discovery of Dual Aβ/Tau Inhibitors and Evaluation of Their Therapeutic Effect on a Drosophila Model of Alzheimer's Disease | Gandini, Annachiara; Gonçalves, Ana Elisa; Strocchi, Silvia; Albertini, Claudia; Janočková, Jana;... Tramarin, Anna; Grifoni, Daniela; Poeta, Eleonora; Soukup, Ondrej; Muñoz-Torrero, Diego; Monti, Barbara; Sabaté, Raimon; Bartolini, Manuela; Legname, Giuseppe; Bolognesi, Maria Laura | 2022-01-01 | ACS CHEMICAL NEUROSCIENCE | - | 1.01 Articolo in rivista | acschemneuro.2c00357.pdf; cn2c00357_si_001.pdf |
Histone Acetylation Defects in Brain Precursor Cells: A Potential Pathogenic Mechanism Causing Proliferation and Differentiation Dysfunctions in Mitochondrial Aspartate-Glutamate Carrier Isoform 1 Deficiency | Poeta E.; Petralla S.; Babini G.; Renzi B.; Celauro L.; Magnifico M.C.; Barile S.N.; Masotti M.; ...De Chirico F.; Massenzio F.; Viggiano L.; Palmieri L.; Virgili M.; Lasorsa F.M.; Monti B. | 2022-01-01 | FRONTIERS IN CELLULAR NEUROSCIENCE | - | 1.01 Articolo in rivista | fncel-15-773709.pdf |
New models of Parkinson’s like neuroinflammation in human microglia clone 3: Activation profiles induced by INF-γ plus high glucose and mitochondrial inhibitors | Francesca De Chirico, Eleonora Poeta, Giorgia Babini, Iliana Piccolino, Barbara Monti, Francesca ...Massenzio* | 2022-01-01 | FRONTIERS IN CELLULAR NEUROSCIENCE | - | 1.01 Articolo in rivista | fncel-16-1038721.pdf |
Epigenetics and Communication Mechanisms in Microglia Activation with a View on Technological Approaches | Sabrina Petralla, Francesca De Chirico, Andrea Miti, Ottavia Tartagni, Francesca Massenzio, Eleon...ora Poeta, Marco Virgili, Giampaolo Zuccheri, Barbara Monti | 2021-01-01 | BIOMOLECULES | - | 1.01 Articolo in rivista | biomolecules-11-00306-v2.pdf |
Melatonin- And Ferulic Acid-Based HDAC6 Selective Inhibitors Exhibit Pronounced Immunomodulatory Effects in Vitro and Neuroprotective Effects in a Pharmacological Alzheimer's Disease Mouse Model | He F.; Chou C.J.; Scheiner M.; Poeta E.; Yuan Chen N.; Gunesch S.; Hoffmann M.; Sotriffer C.; Mon...ti B.; Maurice T.; Decker M. | 2021-01-01 | JOURNAL OF MEDICINAL CHEMISTRY | - | 1.01 Articolo in rivista | Melatonin- and Ferulic Acid-Based HDAC6.docx |
Selective Pseudo-irreversible Butyrylcholinesterase Inhibitors Transferring Antioxidant Moieties to the Enzyme Show Pronounced Neuroprotective Efficacy in Vitro and in Vivo in an Alzheimer's Disease Mouse Model | Scheiner M.; Hoffmann M.; He F.; Poeta E.; Chatonnet A.; Monti B.; Maurice T.; Decker M. | 2021-01-01 | JOURNAL OF MEDICINAL CHEMISTRY | - | 1.01 Articolo in rivista | - |
Deficiency of Mitochondrial Aspartate-Glutamate Carrier 1 Leads to Oligodendrocyte Precursor Cell Proliferation Defects Both In Vitro and In Vivo | Petralla S.; Pena-Altamira L.E.; Poeta E.; Massenzio F.; Virgili M.; Barile S.N.; Sbano L.; Profi...lo E.; Corricelli M.; Danese A.; Giorgi C.; Ostan R.; Capri M.; Pinton P.; Palmieri F.; Lasorsa F.M.; Monti B. | 2019-01-01 | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | - | 1.01 Articolo in rivista | ijms-20-04486.pdf |
Dual-Acting Cholinesterase-Human Cannabinoid Receptor 2 Ligands Show Pronounced Neuroprotection in Vitro and Overadditive and Disease-Modifying Neuroprotective Effects in Vivo | Scheiner M.; Dolles D.; Gunesch S.; Hoffmann M.; Nabissi M.; Marinelli O.; Naldi M.; Bartolini M....; Petralla S.; Poeta E.; Monti B.; Falkeis C.; Vieth M.; Hubner H.; Gmeiner P.; Maitra R.; Maurice T.; Decker M. | 2019-01-01 | JOURNAL OF MEDICINAL CHEMISTRY | - | 1.01 Articolo in rivista | dual acting_am_ 730794.pdf |
Tacrine-O-protected phenolics heterodimers as multitarget-directed ligands against Alzheimer's disease: Selective subnanomolar BuChE inhibitors | Roldan-Pena J.M.; Romero-Real V.; Hicke J.; Maya I.; Franconetti A.; Lagunes I.; Padron J.M.; Pet...ralla S.; Poeta E.; Naldi M.; Bartolini M.; Monti B.; Bolognesi M.; Lopez O.; Fernandez-Bolanos J.G. | 2019-01-01 | EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | - | 1.01 Articolo in rivista | - |